The Personalized Medicine Revolution in Castration-Resistant Prostate Cancer (CRPC): Connecting Epigenetic Landscapes with AI‑Driven RNA Therapeutic Strategies
Journal of Medical Science, Biology, and Chemistry · 07.02.2026 · 3 (1) · 1-10
DOI: 10.69739/jmsbc.v3i1.1378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Science, Biology, and Chemistry, online erschienen am 07.02.2026. Verfasst von Isima Precious Omozusi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Castration-resistant prostate cancer (CRPC) escapes cure despite successive generations of androgen-receptor inhibitors and radiopharmaceuticals. A review of English-language studies published between January 2019 and June 2025 examined epigenetic deregulation, RNA therapeutics, and AI tools. DNA methylation at tumor-suppressor promoters (GSTP1, RASSF1A), histone modifications mediated by EZH2, and enhancer rewiring by pioneer factors such as GATA2 drive resistance and lineage plasticity. RNA modalities, including antisense oligonucleotides targeting the androgen receptor, small interfering RNAs directed at AR splice variants (AR-V7), and self-adjuvanted mRNA vaccines encoding PSA/PSMA/STEAP1, showed preclinical and early clinical activity. AI platforms employing random forests, autoencoders, and generative models integrate multi-omics data to identify combinatorial biomarkers, while machine-learning-guided lipid-nanoparticle design accelerates delivery optimization. These advances position CRPC management for a shift from broad androgen-axis suppression toward stratified, mechanism-based therapies. Realizing this potential requires multidisciplinary collaboration, regulatory adaptation, and deliberate attention to health equity.
Zitieren
APA
Omozusi, I. P., Chikezie, C. O., Nwazuo, K. E., Ezeugwu, E. C., & Ogunmuyiwa, O. M. (2026). The Personalized Medicine Revolution in Castration-Resistant Prostate Cancer (CRPC): Connecting Epigenetic Landscapes with AI‑Driven RNA Therapeutic Strategies. Journal of Medical Science, Biology, and Chemistry, 3(1), 1-10. https://doi.org/10.69739/jmsbc.v3i1.1378
Vancouver
Omozusi IP, Chikezie CO, Nwazuo KE, Ezeugwu EC, Ogunmuyiwa OM. The Personalized Medicine Revolution in Castration-Resistant Prostate Cancer (CRPC): Connecting Epigenetic Landscapes with AI‑Driven RNA Therapeutic Strategies. Journal of Medical Science, Biology, and Chemistry. 2026;3(1):1-10. doi:10.69739/jmsbc.v3i1.1378
BibTeX
@article{Omozusi2026,
author = {Omozusi, Isima Precious and Chikezie, Chizube Obinna and Nwazuo, Kelechi Elizabeth and Ezeugwu, Emmanuel Chidozie and Ogunmuyiwa, Oladimeji Micheal},
title = {The Personalized Medicine Revolution in Castration-Resistant Prostate Cancer (CRPC): Connecting Epigenetic Landscapes with AI‑Driven RNA Therapeutic Strategies},
journal = {Journal of Medical Science, Biology, and Chemistry},
year = {2026},
volume = {3},
number = {1},
pages = {1--10},
doi = {10.69739/jmsbc.v3i1.1378}
}
EUVIMED